Related Experiment Video
Updated: Dec 3, 2025

Generating Whole Bacterial Genomes from Clinical Samples using a Target Enrichment Workflow
Published on: August 15, 2025
Genomic analysis revealed distinct transmission clusters of vancomycin-resistant Enterococcus faecium ST80 in
H Fang1, I Fröding1, M Ullberg2
1Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Abstract:
Vancomycin-resistant Enterococcus faecium (VREfm) belonging to sequence type (ST)80 has become the predominant clonal lineage in Stockholm in the last three years. ST80 accounted for 75% and 46% of VRE cases in 2018 and 2019, respectively, and gave rise to both vanA-type and vanB-type outbreaks. Non-duplicate ST80-VREfm isolates (N = 188) were subjected to whole genome sequencing. Genomic analysis revealed three distinct transmission clusters. Our study indicated that difficulties in detecting low-grade vancomycin-resistant isolates by phenotypic testing might be one of the explanatory factors for the prolonged course of vanB-type outbreaks. Herein, we also report the first optrA-positive linezolid-resistant VRE isolate in Stockholm.
Insights
Sequence type 80 (ST80) vancomycin-resistant Enterococcus faecium (VREfm) is the main cause of VRE infections in Stockholm. Genomic analysis revealed transmission clusters and challenges in detecting resistant isolates.
Area of Science:
- Microbiology
- Genomics
- Epidemiology
Background:
- Vancomycin-resistant Enterococcus faecium (VREfm) poses a significant healthcare challenge.
- Sequence type 80 (ST80) has emerged as a predominant clonal lineage of VREfm in Stockholm.
- ST80 VREfm has been associated with both vanA-type and vanB-type outbreaks.
Purpose of the Study:
- To investigate the genomic epidemiology of ST80 VREfm in Stockholm.
- To identify transmission clusters and understand the drivers of VREfm outbreaks.
- To characterize antimicrobial resistance mechanisms within ST80 VREfm isolates.
Main Methods:
- Whole genome sequencing of 188 non-duplicate ST80-VREfm isolates.
- Genomic analysis to identify distinct transmission clusters.
- Phenotypic testing for vancomycin resistance detection.
Main Results:
- Genomic analysis identified three distinct transmission clusters of ST80 VREfm.
- Difficulties in detecting low-grade vancomycin resistance phenotypically may prolong vanB-type outbreaks.
- The first optrA-positive linezolid-resistant VRE isolate in Stockholm was identified.
Conclusions:
- ST80 VREfm is the predominant lineage driving VRE infections in Stockholm.
- Improved detection methods for low-grade vancomycin resistance are needed.
- Emergence of novel resistance mechanisms, such as optrA, requires ongoing surveillance.

